Showing posts with label u.s. vaccine market share. Show all posts
Showing posts with label u.s. vaccine market share. Show all posts
U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
A
vaccine is a biological preparation of killed forms of microbes,
living attenuated organisms, living fully virulent organisms, a
microbe’s toxins or one of its surface proteins. Vaccines play a
key role in improving immunity against particular diseases.
Therefore, vaccination is promoted as a vital public health
intervention throughout the globe. According to the World Health
Organization (WHO), vaccination has reduced the burden of infectious
disease globally to a great extent. According to a study conducted by
Zhou et al, vaccination prevented 42,000 early deaths and
approximately 20 million cases of diseases in children born in the
U.S. in 2009, resulting in saving USD 13.5 billion in direct medical
and non-medical costs and USD 68.8 billion in total societal costs.
This
report on the U.S. vaccine market offers an insightful and in-depth
assessment of the current as well as future market potential of human
as well as animal vaccine markets. The human vaccine market is
further segmented into pediatric and adult vaccine markets, based on
vaccine type. On the basis of different antigens, the U.S. human
vaccine market has been categorized into hepatitis, influenza,
meningococcal, pneumococcal, human papillomavirus (HPV), combination
vaccines and others. The U.S. animal vaccine market is broadly
segmented as companion animal and livestock vaccine markets. The U.S.
companion animal vaccine market segment has been further categorized
into canine and feline, while the livestock vaccine market has been
divided into porcine, bovine, ovine, poultry and equine markets.
Browse Here For Full Report With
ToC:http://www.transparencymarketresearch.com/us-vaccine-market.html
Each
of these segments and sub-segments has been extensively analyzed in
the report, considering factors such as market trends, recent
developments, future outlook and opportunities. The report provides
market revenue size in terms of USD million for each segment and
sub-segment for the period 2012 to 2020. In addition, the compounded
annual growth rate (CAGR) of the overall U.S. vaccine market and
various segments and sub-segments has also been provided in the
report for the forecast period 2014 to 2020, considering 2012 and
2013 as the base years. Extensive pricing analysis for human as well
as animal vaccine market has been provided in the report.
This
report includes an elaborate executive summary, which covers a market
snapshot representing key findings from the study on the U.S. vaccine
market. The market overview section of the report on the U.S. vaccine
market comprises qualitative analysis of the overall market
considering factors determining market dynamics such as growth
drivers, restraints and opportunities. The market overview chapter
also includes a section describing the vaccine approval and
regulatory pathway in the U.S. The competitive landscape section has
been provided for both human and animal vaccine markets. This section
presents the market revenue share of key players in terms of
percentage for the year 2013. The market share analysis of key
players involved the study of company product portfolio and sales
revenue along with market developments such as new product launch and
regulatory approvals.
Press Here For Press Release OF This Report
http://www.transparencymarketresearch.com/pressrelease/us-vaccine-market-research.htm
This
study on the U.S. vaccine market suggests a list of recommendations
for new companies willing to enter the market and for existing
companies to accentuate revenue shares, which is likely to help in
the decision-making process. The report concludes with the profiles
of major players in the U.S. vaccine market such as GlaxoSmithKline
plc, Merck & Co., Inc., Novartis International AG, Pfizer, Ltd.,
Sanofi, Boehringer Ingelheim and Zoetis, Inc. Each company profile in
the report contains information such as company overview, financial
overview, product portfolio, business strategies and recent
developments. The company overview section comprises basic
information about the company such as major business areas, company’s
brief history and its establishment year, number of employees and
geographical presence. In the financial overview section, information
such as selling and general administrative expenses, R&D expenses
and annual revenue for the last three consecutive years (2011, 2012
and 2013) has been provided. The business strategies section mentions
key strategies adopted by the company in the past to strengthen its
position in the vaccine market. The recent development section gives
information about the recent happening in the company related with
the vaccine market.
Click Here For Requesting Sample Of This Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=553
The
U.S. vaccine market is segmented as follows:
U.S.
Human Vaccine Market, by Type
Pediatric
Adult
U.S.
Human Vaccine Market, by Antigen
Hepatitis
(A & B)
Influenza
Meningococcal
Pneumococcal
Human
Papillomavirus (HPV)
Combination
Vaccines (DTaP, DTaP-Hep B-IPV, DTaP-IPV and DTaP-IPV)
Others
U.S.
Animal Vaccine Market, by Animal Type
Companion
Animal Vaccine Market
Canine
Feline
Livestock
Vaccine Market
Porcine
Bovine
Ovine
Poultry
Equine
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge
Contact Us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Subscribe to:
Posts
(
Atom
)
